Rune Rose Tronstad

Guest Researcher

Academic article

Show author(s) (2021). Bridging the Gap for Children With Compound Health Challenges: An Intervention Protocol. Frontiers in pediatrics. 1-8.

Show author(s) (2020). Plasma levels of guanylins are reduced in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology. 449-453.

Show author(s) (2018). Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea. Scandinavian Journal of Gastroenterology. 1264-1273.

Show author(s) (2017). Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation. PLOS ONE.
Show author(s) (2017). Guanylate cyclase C activation shapes the intestinal microbiota in patients with familial diarrhea and increased susceptibility for Crohn's disease. Inflammatory Bowel Diseases. 1752-1761.

Show author(s) (2016). Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents. Journal of Immunology Research.
Show author(s) (2016). An activating gucy2c mutation causes impaired contractility and fluid stagnation in the small bowel. Scandinavian Journal of Gastroenterology. 1308-1315.
Show author(s) (2016). A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients with Common Variable Immunodeficiency. American Journal of Gastroenterology. 1467-1475.

Show author(s) (2012). Familial diarrhea syndrome caused by an activating GUCY2C mutation. New England Journal of Medicine. 1586-1595.

Doctoral dissertation

Show author(s) (2019). Clinical and molecular effects of guanylate cyclase C-activation.